Shanxi Kangbao Biological Product Co., Ltd.

This study tested a new medicine called LP-98, given as multiple injections under the skin, in 40 people with HIV who had never taken HIV drugs before. The main goal was to check if the injections are safe and how the body processes them. Researchers also looked at how well the d…

This study tested a new medicine called Lipovirtide, combined with standard HIV drugs, in 64 adults with HIV who had never been treated before. The goal was to see if the combination could lower the amount of virus in the blood to very low levels. The study is complete, but resul…

This early-stage study tested a single injection of a new drug, lipovirtide, in 46 HIV-positive adults who had never taken antiviral medication. The main goal was to see if the drug is safe and how the body processes it. This is a first step in developing a potential new treatmen…

This early-stage study tested a new injectable drug, Lipovirtide, in 24 adults with HIV who were not taking any other HIV medications. The main goal was to check if the drug is safe and tolerable. Researchers also looked at how the drug works in the body and whether it can lower …

This early-stage study tested a single injection of LP-98 in 36 healthy adults to see if it is safe and how the body processes it. The goal was not to treat or prevent HIV, but to gather initial safety data. Participants were closely monitored for side effects and changes in vita…